OTCMKTS:ENDVD Endonovo Therapeutics (ENDVD) Stock Price, News & Analysis → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free ENDVD Stock Alerts $0.0022 0.00 (0.00%) (As of 05/6/2024 ET) Add Compare Share Share Today's Range$0.0019▼$0.002250-Day Range N/A52-Week Range$1.10▼$37.90Volume80,110 shsAverage Volume11,850 shsMarket Capitalization$2,681.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Endonovo Therapeutics alerts: Email Address Ad The Oxford ClubOil Surge Predicted... But Are You ReadyDo you own oil and gas stocks? Or are you thinking about buying some? If so, you need to see this.All the details are right here: About Endonovo Therapeutics Stock (OTCMKTS:ENDVD)Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development of bio-electronic approach to regenerative medicine. The firm also develops, manufactures and distributes evolutionary medical devices focused on the healing of wounds and reduction of pain, edema and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, SofPulse, Electroceutical Therapy, and Scientific Studies. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.Read More ENDVD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ENDVD Stock News HeadlinesMarch 6, 2023 | investing.comEndonovo Therapeutics, Inc. Announces Distribution Agreement with Academy MedicalSee More Headlines Receive ENDVD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:ENDVD CUSIPN/A CIKN/A Webendonovo.com Phone(800) 489-4774FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-400,000.00 Net Margins-6,075.54% Pretax MarginN/A Return on EquityN/A Return on Assets-279.35% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$170,000.00 Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value($0.59) per share Price / Book0.00Miscellaneous Outstanding Shares1,227,000Free FloatN/AMarket Cap$2,681.00 OptionableNot Optionable Beta1.98 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesAlan Brian CollierChairman, CEO, CFO & SecretaryDon CalabriaVice President-OperationsDavid ClarkVice President-SalesSteven FordVice President-MarketingSteven BarnesInvestor Relations ContactKey CompetitorsOncoSec MedicalNASDAQ:ONCSQRegeneRx BiopharmaceuticalsOTCMKTS:RGRXSienna BiopharmaceuticalsOTCMKTS:SNNAQSophiris BioOTCMKTS:SPHSTetraLogic PharmaceuticalsOTCMKTS:TLOGView All Competitors ENDVD Stock Analysis - Frequently Asked Questions How have ENDVD shares performed in 2024? Endonovo Therapeutics' stock was trading at $0.0087 on January 1st, 2024. Since then, ENDVD stock has decreased by 74.9% and is now trading at $0.0022. View the best growth stocks for 2024 here. How do I buy shares of Endonovo Therapeutics? Shares of ENDVD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ENDVD) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressOil Surge Predicted... But Are You ReadyThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceWarren Buffet Stockpiling Gold?Reagan Gold GroupControversial CEO explains new way to amass wealthStansberry ResearchThe 2024 crypto bull run has already started — don’t get left behindInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endonovo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.